已收录 268921 条政策
 政策提纲
  • 暂无提纲
Risk of Thromboembolic Events Following COVID-19 Diagnosis Without Hospitalization
[摘要] Introduction: Current research shows no increased risk of thromboembolic events with mild COVID-19 but does not account for comorbidities. The aim of this study was to examine the incidence of thromboembolic events, including pulmonary embolism, cerebral infarction, and deep vein thrombosis, in nonhospitalized patients diagnosed with COVID-19 while accounting for comorbidities such as diabetes, asthma, COPD and cancer.Methods: We completed a large retrospective observational analysis of adult patients within a large urban health system.Results: Using a logit framework (with and without propensity score weighting), there was no increased risk of thromboembolic events among patients positive for SARS-CoV-2 who did not require hospitalization for COVID-19.Conclusion: This data suggest prophylactic anticoagulation is likely not warranted in the outpatient setting.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 过敏症与临床免疫学
[关键词] Anticoagulants;COVID-19;Incidence;Retrospective Studies;SARS-CoV-2;Urban Health;Venous Thromboembolism [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文